Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage

BACKGROUND: Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among men diagnosed with prostate cancer. Piperlongumine (PL) is a novel potential anticancer agent that has been demonstrated to exhibit anticancer efficacy against prostate cancer cells. However, the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ding-fang, Yang, Zhi-chun, Chen, Jian-qiang, Jin, Xiang-xiang, Qiu, Yin-da, Chen, Xiao-jing, Shi, Hong-yi, Liu, Zhi-guo, Wang, Min-shan, Liang, Guang, Zheng, Xiao-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261967/
https://www.ncbi.nlm.nih.gov/pubmed/34229670
http://dx.doi.org/10.1186/s12906-021-03369-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261967/
https://www.ncbi.nlm.nih.gov/pubmed/34229670
http://dx.doi.org/10.1186/s12906-021-03369-0

Ejemplares similares